Incyte | DETTE



Debt Changement Date
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Eli Lilly USD 39.9B 1.39B 2025-06
Exelixis USD 179.84M 179.84M 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 60.93B 1.18B 2025-06
PTC Therapeutics USD 286.01M 2.12B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Incyte DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.